Type 2 diabetes impairs splanchnic uptake of glucose but does not alter intestinal glucose absorption during enteral glucose feeding: additional evidence for a defect in hepatic glucokinase activity
- PMID: 11375336
- DOI: 10.2337/diabetes.50.6.1351
Type 2 diabetes impairs splanchnic uptake of glucose but does not alter intestinal glucose absorption during enteral glucose feeding: additional evidence for a defect in hepatic glucokinase activity
Abstract
We have previously reported that splanchnic glucose uptake, hepatic glycogen synthesis, and hepatic glucokinase activity are decreased in people with type 2 diabetes during intravenous glucose infusion. To determine whether these defects are also present during more physiological enteral glucose administration, we studied 11 diabetic and 14 nondiabetic volunteers using a combined organ catheterization-tracer infusion technique. Glucose was infused into the duodenum at a rate of 22 micromol. kg(-1). min(-1) while supplemental glucose was given intravenously to clamp glucose at approximately 10 mmol/l in both groups. Endogenous hormone secretion was inhibited with somatostatin, and insulin was infused to maintain plasma concentrations at approximately 300 pmol/l (i.e., twofold higher than our previous experiments). Total body glucose disappearance, splanchnic, and leg glucose extractions were markedly lower (P < 0.01) in the diabetic subjects than in the nondiabetic subjects. UDP-glucose flux, a measure of glycogen synthesis, was approximately 35% lower (P < 0.02) in the diabetic subjects than in the nondiabetic subjects. This was entirely accounted for by a decrease (P < 0.01) in the contribution of extracellular glucose because the contribution of the indirect pathway to hepatic glycogen synthesis was similar between groups. Neither endogenous and splanchnic glucose productions nor rates of appearance of the intraduodenally infused glucose in the portal vein differed between groups. In summary, both muscle and splanchnic glucose uptake are impaired in type 2 diabetes during enteral glucose administration. The defect in splanchnic glucose uptake appears to be due to decreased uptake of extracellular glucose, implying decreased glucokinase activity. Thus, abnormal hepatic and muscle (but not gut) glucose metabolism are likely to contribute to postprandial hyperglycemia in people with type 2 diabetes.
Similar articles
-
Effects of type 2 diabetes on the ability of insulin and glucose to regulate splanchnic and muscle glucose metabolism: evidence for a defect in hepatic glucokinase activity.Diabetes. 2000 Feb;49(2):272-83. doi: 10.2337/diabetes.49.2.272. Diabetes. 2000. PMID: 10868944
-
Type I diabetes mellitus does not alter initial splanchnic glucose extraction or hepatic UDP-glucose flux during enteral glucose administration.Diabetologia. 2001 Jun;44(6):729-37. doi: 10.1007/s001250051682. Diabetologia. 2001. PMID: 11440366
-
Effects of free fatty acids and glycerol on splanchnic glucose metabolism and insulin extraction in nondiabetic humans.Diabetes. 2002 Feb;51(2):301-10. doi: 10.2337/diabetes.51.2.301. Diabetes. 2002. PMID: 11812736
-
Hepatic glucose uptake, gluconeogenesis and the regulation of glycogen synthesis.Diabetes Metab Res Rev. 2001 Jul-Aug;17(4):250-72. doi: 10.1002/dmrr.217. Diabetes Metab Res Rev. 2001. PMID: 11544610 Review.
-
Regulation of hepatic glucose uptake and storage in vivo.Adv Nutr. 2012 May 1;3(3):286-94. doi: 10.3945/an.112.002089. Adv Nutr. 2012. PMID: 22585902 Free PMC article. Review.
Cited by
-
Hyperglycemia Induced by Glucokinase Deficiency Accelerates Atherosclerosis Development and Impairs Lesion Regression in Combined Heterozygous Glucokinase and the Apolipoprotein E-Knockout Mice.J Diabetes Res. 2016;2016:8630961. doi: 10.1155/2016/8630961. Epub 2016 Sep 28. J Diabetes Res. 2016. PMID: 27774459 Free PMC article.
-
Recent Advances Regarding the Physiological Functions and Biosynthesis of D-Allulose.Front Microbiol. 2022 Apr 14;13:881037. doi: 10.3389/fmicb.2022.881037. eCollection 2022. Front Microbiol. 2022. PMID: 35495640 Free PMC article. Review.
-
Transaldolase exchange and its effects on measurements of gluconeogenesis in humans.Am J Physiol Endocrinol Metab. 2011 Feb;300(2):E296-303. doi: 10.1152/ajpendo.00403.2010. Epub 2010 Nov 9. Am J Physiol Endocrinol Metab. 2011. PMID: 21062960 Free PMC article.
-
A physiological increase in the hepatic glycogen level does not affect the response of net hepatic glucose uptake to insulin.Am J Physiol Endocrinol Metab. 2009 Aug;297(2):E358-66. doi: 10.1152/ajpendo.00043.2009. Epub 2009 May 26. Am J Physiol Endocrinol Metab. 2009. PMID: 19470836 Free PMC article.
-
Macroalgal protein hydrolysates from Palmaria palmata influence the 'incretin effect' in vitro via DPP-4 inhibition and upregulation of insulin, GLP-1 and GIP secretion.Eur J Nutr. 2021 Dec;60(8):4439-4452. doi: 10.1007/s00394-021-02583-3. Epub 2021 Jun 3. Eur J Nutr. 2021. PMID: 34081167 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous